Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    Plastics in Transition

    Technology insight report on plastic waste management

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventors Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Water-related technologies
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Technologies
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2024 activities
        • 2025 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Water-related technologies
      • CodeFest
        • Go back
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • Daily D questions
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • The PATLIB Knowledge Transfer to Africa initiative (KT2A)
          • KT2A core activities
          • Success story: Malawi University of Science and Technology and PATLIB Birmingham
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Technologies
        • Go back
        • Overview
        • Innovation against cancer
        • Assistive robotics
        • Space technologies
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
          • Go back
          • Overview
          • Publications
        • Research universities and public research organisations
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 1188/06 (Molecular evolution/BIOINVENT) 18-10-2007
Facebook X Linkedin Email

T 1188/06 (Molecular evolution/BIOINVENT) 18-10-2007

European Case Law Identifier
ECLI:EP:BA:2007:T118806.20071018
Date of decision
18 October 2007
Case number
T 1188/06
Petition for review of
-
Application number
98901380.0
IPC class
C12N 15/10
Language of proceedings
EN
Distribution
NO DISTRIBUTION (D)

Download and more information:

Decision in EN 45.8 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

A method for in vitro molecular evolution of protein function

Applicant name
BioInvent International AB
Opponent name

MAXYGEN INC.

NOVOZYMES A/S

Board
3.3.08
Headnote
-
Relevant legal provisions
European Patent Convention Art 54 1973
European Patent Convention Art 56 1973
European Patent Convention Art 83 1973
European Patent Convention Art 123(3) 1973
Keywords

Main request - extension of protection - yes

Auxiliary request 1 - novelty - yes

Inventive step - yes

Sufficiency of disclosure - yes

Catchword
-
Cited decisions
T 0019/90
T 0187/91
T 0210/93
Citing decisions
-

I. The patentee (appellant) lodged an appeal against the decision of the opposition division dated 26 May 2006, whereby European patent 0 988 378 was revoked. The patent had been granted on European patent application No. 98 901 380.0 entitled "A method for in vitro molecular evolution of protein function" and published under the international publication number WO 98/32845.

II. The patent had been opposed by two opponents. The grounds for opposition relied on were lack of novelty (Article 100(a) EPC), lack of inventive step (Article 100(a) EPC) and insufficiency of disclosure (Article 100(b) EPC).

III. Basis for the revocation were the claims as granted (main request) and eleven auxiliary requests. The main request was refused for reason of lack of novelty of claim 3 over document D12 (see Section IX, infra). Auxiliary requests 1 and 11 were considered not to involve an inventive step in view of document D3 (see Section IX, infra) taken as the closest prior art in combination with any one of the numerous documents relating to gene splicing by overlap extension methodology. Auxiliary requests 2 to 10 were found to lack novelty vis-à-vis document D13 (see Section IX, infra).

IV. Together with its statement setting out the grounds of appeal dated 25 September 2006, the appellant filed a new main request and 14 auxiliary requests (1 to 14) to replace all the claim requests on file.

V. Each of the two respondents (the two opponents) filed observations on the statement setting out the grounds of appeal in letters dated 21 February 2007.

VI. The Board issued a communication pursuant to Article 11(1) of the Rules of Procedure of the Boards of Appeal in which provisional and non-binding opinions were expressed.

VII. With a letter dated 17 September 2007, the appellant filed additional submissions as well as a new main request and ten new auxiliary requests (1 to 10) to replace all previous requests.

Claim 1 of the main request was derived from independent claim 17 as granted and read as follows with omissions shown in square brackets and additions in bold:

"1. A method of creating a polynucleotide library comprising the steps of obtaining [a] parent polynucleotides each encoding one or more variant protein motifs;

a) providing a plurality of pairs of oligonucleotides, each pair representing spaced apart locations on the parent polynucleotide sequences bounding an intervening variant protein motif, and using each said pair of oligonucleotides as amplification primers for PCR to amplify the intervening motif;

b) obtaining single-stranded nucleotide sequences from the thus-isolated amplified nucleotide sequences;

c) assembling polynucleotide sequences by incorporating nucleotide sequences derived from step b) above with nucleotide sequences encoding scaffold sequences; and

d) inserting said polynucleotide sequences into suitable vectors."

Auxiliary request 1 consisted of 8 claims corresponding identically (except for the renumbering and adaptation of back-references) to claims 17 to 20 and claims 23 to 26 as granted. Claim 1 read as follows:

"1. A method of creating a polynucleotide library comprising the steps of obtaining a parent polynucleotide encoding one or more variant protein motifs;

a) providing a plurality of pairs of oligonucleotides, each pair representing spaced apart locations on the parent polynucleotide sequence bounding an intervening variant protein motif, and using each said pair of oligonucleotides as amplification primers for PCR to amplify the intervening motif;

b) obtaining single-stranded nucleotide sequences from the thus-isolated amplified nucleotide sequences;

c) assembling polynucleotide sequences by incorporating nucleotide sequences derived from step b) above with nucleotide sequences encoding scaffold sequences; and

d) inserting said polynucleotide sequences into suitable vectors."

Claims 2 to 8 of both requests were dependent on claim 1 and directed to particular embodiments thereof.

VIII. Oral proceedings took place on 18 October 2007.

IX. The following documents are referred to in the present decision:

(D3) WO 97/08320 published on 6 March 1997

(D9) Eskil Söderlind et al., Gene, Vol. 160, 1995, Pages 269 to 272

(D12) Robert M. Horton et al., Gene, Vol. 77, 1989, Pages 61 to 68

(D13) WO 98/27230 published on 25 June 1998 with a priority date of 18 December 1996

(D14) WO 98/42832 published on 1 October 1998 with a first priority date of 25 March 1997

(D25) Robert M. Horton et al., Methods in Enzymology, Vol. 217, 1993, Pages 270 to 279

(D29) P. Jirholt et al., Gene, Vol. 215, 1998, Pages 471 to 476

X. The submissions made by the appellant (patentee), insofar as they are relevant to the present decision, may be summarised as follows:

Main request (Article 123(3) EPC)

The use of more than one parent polynucleotide as a source of variant protein motifs was an inherent feature of claim 17 as granted. Therefore, the replacement in claim 17 as granted of the expression "a parent polynucleotide" by the expression "parent polynucleotides" had not extended the protection conferred by the patent. The reasoning in decision T 187/91 of 11 March 1993 applied to the present case.

Auxiliary request 1

Novelty (Article 54 EPC)

Document D12 reported the use of gene splicing by overlap extension to construct a recombinant gene encoding a mosaic fusion protein comprised of parts of two different mouse class-I major histocompatibility genes. It did not disclose a method of creating a polynucleotide library.

The method of document D13 differed from the method of claim 1 at least in that there was no amplification of the parent polynucleotides and bridge primers were used. The disclosure in the only specific passage in the document (see Section (g) on page 71) referring to the "gentle" fine grain search was not clear. As a result, there was no direct and unambiguous disclosure of the method of claim 1.

As for document D14, the mention of "two genes" in the legend to Figure 2 therein could not be seen as a direct and unambiguous disclosure of a polynucleotide encoding a variant protein motif. Furthermore, Figure 2 did not illustrate the production of a polynucleotide library, but of only two variant sequences. In the method of Example 3 there was no amplification of an intervening variant protein motif. This was evident from page 21, lines 10 to 18 which described the product as "a large smear", i.e. not one amplified sequence. As derivable from Figure 5, there was no amplification of the two parent polynucleotides.

Inventive step (Article 56 EPC)

Document D9 focused on the construction entirely in vitro of totally synthetic gene libraries for the variable light chain. The intention of the authors was to find a method which did not depend on in vivo pre-formed antibody specificities. The whole concept of the method of document D9 was to make a synthetic library by use of randomised oligonucleotides. It was an alternative to methods which involved pre-existing variant sequences. Thus, document D9 taught away from the use of regions from pre-formed sequences. The skilled person looking for a source of variant sequences would not have replaced the chemical synthesis of the method of document D9 by an amplification of pre-formed variant sequences obtained from a parent polynucleotide.

Sufficiency of disclosure (Article 83 EPC)

It was not derivable from document D29 that the use of a member of a specific binding pair, such as biotin, was critical to obtain single-stranded sequences. In this respect, document D29 failed to provide any serious doubts, substantiated by verifiable facts. The respondents failed to explain why obtaining single-stranded sequences would cause a skilled person any difficulty whatsoever.

XI. The submissions made by respondent I (opponent 1), insofar as they are relevant to the present decision, may be summarised as follows:

Main request (Article 123(3) EPC)

No objection was made.

Auxiliary request 1

Novelty (Article 54 EPC)

Claim 1 was not new over document D12 which disclosed the basic SOEing methodology (gene Splicing by Overlap Extension), an approach for recombining DNA molecules at precise junctions without the use of restriction endonucleases or ligase. All the steps of the method of claim 1 were indicated in Figure 1 (see page 63). This was in particular the case for the step of "obtaining single-stranded nucleotide sequences", account being taken of the fact that single-stranded nucleotide sequences were always produced as a first step in oligo-directed recombination reactions (as shown in Figure 2 on page 64 of document D12).

Claim 1 was not new over the disclosure in document D13 of a "gentle fine grain" method for evolution of proteins and its application to interferon alpha. The object of the method was the creation of a polynucleotide library (see page 71, lines 15 to 17). Each of the nine degenerate oligonucleotides was amplified by PCR. Thus, it involved a step of providing a plurality of pairs of oligonucleotides, as in claim 1, and a step of obtaining single-stranded nucleotide sequences, because single-stranded sequences were inevitably produced during the cycling steps of denaturation, reannealing and primer extension used in PCR. Full-length genes were generated using the oligonucleotide directed recombination method (see page 70). This was the same assembly method as used in claim 1. Thus, the "gentle fine grain" method included the step of "assembling polynucleotide sequences" of claim 1. It also provided the claimed step of "obtaining single-stranded nucleotide sequences", because single-stranded nucleotide sequences were always produced as a first step in oligo-directed recombination reactions.

As for document D14, Example 3 therein described the production and screening of multiple recombinant sequences. The method was schematically illustrated in Figure 2. Two pNB esterase genes were recombined using the "defined primer" recombination technique. This was a disclosure of a method of creating a polynucleotide library as required by claim 1.

Inventive step (Article 56 EPC)

Either of documents D3 and D9 could be chosen as the closest prior art. The method of creating a polynucleotide library described in document D9 differed from the method of claim 1 only in the source of the variant sequences. In the method of document D9, the variant sequences were chemically synthesized whereas in the method of claim 1 they were amplified pre-formed sequences taken from a parent polynucleotide. From common general knowledge the skilled person would have regarded it as obvious to replace in the method of document D9 the chemical synthesis of the variant sequences by such an amplification synthesis.

Sufficiency of disclosure (Article 83 EPC)

The presence of a member of a specific binding pair (MSBP) such as biotin linked to one member of each primer pair was the only way indicated by the opposed patent for isolating the single-stranded nucleotide sequences referred to in step b) of claim 1. As the patent did not indicate how methods not involving any MSBP could be carried out, it failed to provide an enabling disclosure.

XII. The submissions made by respondent II (opponent 2), insofar as they are relevant to the present decision, were essentially the same as those made by respondent I. Additional comments were made which can be summarized as follows:

Main request (Article 123(3) EPC)

The replacement in claim 1 of the expression "a parent polynucleotide" by the expression "parent polynucleotides" resulted in the extension of the protection conferred by the patent. The source of variant protein motifs and of scaffolds had been diversified.

Auxiliary request 1

Novelty (Article 54 EPC)

As regards document D12, the reported use of gene splicing by overlap extension to construct a recombinant gene was relevant even if the creation of a polynucleotide library was not referred to therein because in the characterising part of claim 1 there was no step indicating how the library referred to in its preamble was to be prepared. Furthermore, the reasoning of decision T 210/93 of 12 July 1994 applied when assessing novelty over document D12.

As regards document D13, its disclosure was not limited to interferon alpha on which Example 3 was focused but was concerned with polypeptides in general. Thus, it provided a general disclosure of the method of claim 1.

For the same reasons indicated by respondent I, claim 1 lacked novelty also over document D14.

Inventive step (Article 56 EPC)

Starting from either document D3 or document D9, chosen as the closest prior art, the person skilled in the art would have regarded it as obvious to modify the method described therein by using the gene splicing by overlap extension technology as described in particular in document D12 or document D25.

Sufficiency of disclosure (Article 83 EPC)

For the same reasons indicated by respondent I, the method of claim 1 was not sufficiently disclosed.

XIII. The appellant (patentee) requested that the decision under appeal be set aside and the patent be maintained on the basis of the main request or one of the auxiliary requests 1 to 10 filed on 17 September 2007.

XIV. The respondents (opponents) requested that the appeal be dismissed.

1. Main request

1.1 Claim 1 of the main request, which is directed to a method of creating a polynucleotide library, differs from claim 17 as granted from which it derives (see Section VII, supra) in that its starting point is no longer a step of obtaining "a parent polynucleotide" but a step of obtaining "parent polynucleotides". Because each parent polynucleotide is per se a source of variant motifs and possibly of scaffolds, the method of claim 1 allows the creation of a library containing a multiplicity of polynucleotides which cannot be obtained with the method of claim 17 as granted. Thus, this is a marked difference which has resulted in an extension of the scope of the protection conferred by the patent, a further consideration being that none of the other independent claims as granted can be read in the plural since they use the wording "a parent polynucleotide".

1.2 In support of claim 1, the appellant argues that the rationale of decision T 187/91 (see Section X, supra) applies in the present case. However, in that decision the Board had to deal with an issue of added matter under Article 123(2) EPC, not an issue of extension of protection under Article 123(3) EPC. Therefore, the argument is not tenable.

1.3 Thus, claim 1 contravenes Article 123(3) EPC and the main request is refused.

2. Auxiliary request 1

2.1 Novelty (Article 54 EPC)

2.1.1 Claim 1 is directed to a method for creating a polynucleotide library which comprises a number of steps, namely the step of obtaining a parent polynucleotide and steps (a) to (d) which are essential to its performance.

2.1.2 Three documents, namely D12, D13 and D14, are cited against claim 1. Documents D13 and D14 are cited under Article 54(3) EPC in view of the fact that claim 1 is admittedly only entitled to 26 January 1998 as its filing date and not to 24 January 1997, the claimed priority date, as the priority document covers only a method in which one of the pairs of oligonucleotides provided in step a) is always linked to a member of a specific binding pair (MSBP), a feature which is absent from claim 1.

2.1.3 Document D12 describes the use of a polymerase chain reaction-based approach to genetic engineering called "gene Splicing by Overlap Extension" (SOE) which does not depend on the occurrence of restriction enzyme recognition sequences at the recombination site to construct a gene encoding a mosaic fusion protein comprised of parts of two different mouse class-I major histocompatibility genes. The ambit of document D12 does not go beyond the construction of individual genes. The general mechanism of SOE as illustrated in Figure 1 (see page 63) involves a succession of steps which allows the construction of a particular recombinant product and its amplification as soon as it is formed. There is no disclosure of a method for creating a polynucleotide library.

2.1.4 Respondent II argues that nevertheless the rationale of decision T 210/93 (see Section XII, supra) should apply to the present case. This argument is not tenable as there is no disclosure in document D12 of a method inevitably leading to a polynucleotide library. Although the SOE technology was known at the filing date, there is no information in document D12 from which it could be derived that a polynucleotide library would be inevitably obtained, even when considering the mere speculative statement found at the top of page 62 that "[T]he SOE approach is a fast, simple, and extremely powerful way of recombining and modifying nucleotide sequences".

2.1.5 Thus, the method of claim 1 is new over document D12.

2.1.6 Document D13 describes methods for polypeptide engineering relying on recursive sequence recombination and involving one of two search strategies classified as "coarse grain shuffling" and "fine grain shuffling" which allow analysis of variation occurring within a nucleic sequence. Section (e) (see page 70) describes how to carry out a fine grain search when looking for improved interferon (IFN) alpha hybrids. The modelled structure of IFN alpha has been divided into nine adjacent and non-overlapping segments (see Table III on page 69). Each of the nine segments is synthesized as well as two sets of degenerate oligonucleotides encoding the nine segments. Each of the nine synthetic segments is then amplified by PCR with the 18 PCR oligonucleotides. Full length genes using the oligo direct recombination method are generated, transfected into a host, and assayed for hybrids with desired properties.

2.1.7 The respondents argue that Section (g)) (see page 71) describes a particular embodiment of the fine grain shuffling which corresponds to the method according to claim 1.

2.1.8 In reality, Section (g) is only a brief (8 lines) and merely speculative (as the use of the conditional tense underlines) passage of the description which only suggests to make the fine grain search as reported in section (e) more "gentle", this being supposedly achieved by obtaining a candidate starting point, such as the "IFN-Con1 consensus interferon" and "gently" searching from there. This disclosure is insufficient to provide the skilled person with a clear view of how Section (g) actually combines with Section (e). Thus, the information provided by Section (g) does not amount to a clear and unambiguous disclosure as required for an assessment of novelty. Therefore, claim 1 is new over document D13.

2.1.9 Document D14 describes a method for in vitro mutagenesis and recombination of polynucleotide sequences using interspersed internal "defined primers". (see Figure 2 in which the method is schematised). Rather than reassembling recombined genes from a fragment pool, the "defined primer" method prepares full-length recombined genes in the presence of templates by a process, designated as the "staggered extension" process (StEP). This process consists of priming the template sequences followed by repeated cycles of denaturation and extremely abbreviated annealed/polymerase-catalysed extension. In each cycle the growing fragments anneal to different templates based on sequence complementarity and extend further. This is repeated until full-length sequences form. The method is illustrated in Example 3 with describes the recombination of two pNB esterase genes (see also Figure 5).

2.1.10 A comparison of the "defined primer" method of D14 with the method of claim 1 immediately reveals a major difference therebetween. Whereas the method of claim 1 at issue starts from a parent polynucleotide, the "defined primer" method of document D14 requires as its starting material the presence of (at least) two different parent polynucleotides, as evidenced by Figure 2 (see the comments thereon made from line 32 on page 5 to line 3 on page 6) and Example 3, in which two template pNB esterase genes, referred to as 2-13 and 5-B12, were recombined (see also Figure 5 together with the comments thereon made on page 6, lines 24 to 31). This difference is in itself sufficient to establish novelty of the method of claim 1 over document D14.

2.1.11 Thus, claim 1 meets the requirements of Article 54 EPC. The same conclusion applies de facto to the particular embodiments covered by dependent claims 2 to 8.

2.2 Inventive step (Article 56 EPC)

2.2.1 Each of documents D3 and D9 has been taken as the closest prior art in the decision under appeal.

2.2.2 According to established jurisprudence of the EPO Boards of appeal the closest prior art for assessing inventive step is normally a prior art document disclosing subject-matter conceived for the same purpose or aiming at the same objective as the claimed invention and having the most relevant technical features in common.

2.2.3 Document D3 discloses a method that enables the creation of useful libraries of polypeptides (see page 5, line 2), which can be expressed in a suitable vector and screened for a desired property (see page 7, lines 5 to 22). The method is primarily based on a bioinformatics approach. It includes the computer-aided design of a limited set of synthetic nucleic acid consensus sequences. Starting from the identification and analysis of a collection of at least three homologous proteins, a database is established in which the individual sequences are aligned to each other. For each subgroup of protein sequences, a polypeptide consensus sequence is deduced. These artificial polypeptide consensus sequences are analysed to identify unfavourable interactions which are then removed by altering the consensus sequences accordingly. Then the artificial polypeptide consensus sequences are each back-translated into a corresponding nucleic acid sequence and a set of cleavage sites is set up in each nucleic acid subsequence encoding a structural element (see page 5, first paragraph and claim 1). These cleavage sites are essential to generate new nucleotide sequences. They are used to excise and replace modules with a different sequence compatible with the cleaved nucleic acid.

2.2.4 Document D9 discloses a method for producing a completely synthetic gene library encoding the variable light (VL) immunoglobulin domains (see the abstract on page 269). The method allows cloning and selection of the antibody fragments in any phage display system (see page 270, left-hand column).

2.2.5 Whereas, as explained at point 2.2.9 (see infra), the method of document D9 differs from the method of claim 1 only in that the step of obtaining the variant protein motifs relies on a different technology, in stark contrast, as outlined at point 2.2.3 (see supra), the method of document D3 is based on a fundamentally different concept, according to which not a parental polynucleotide serves as the starting point but a series of computer-aided designed nucleic acid sequences incorporating cleavage sites.

2.2.6 Thus, although the methods disclosed in both documents D3 and D9 belong to the same technical field as the claimed method (creation of a polynucleotide library) and are directed to a similar purpose or effect as the invention (increasing genetic variation with the objective of selecting proteins with desired characteristics), not document D3 but document D9 represents the closest state of the art.

2.2.7 The method of document D9 is illustrated schematically in Figure 2. A 374-bp sequence, covering the entire variable light (VL) domain of a known anti-lysozyme antibody, was divided into six regions represented by six synthetic oligodeoxyribonucleotides (see the six overlapping internal primers L1 to L6 of Figure 2). Internal primers L2, L3 and L5 were synthesized with randomized complementary determining regions (CDRs). The framework regions were unaltered. They correspond to internal primers L1, L4 and L6. Furthermore, two flanking primers (see the two amplification primers of Figure 2) were used in the assembly process to permit desired restriction sites to be engineered into the synthetic libraries and allow cloning and selection of antibody fragments in any phage display system. The synthetic library for the VL domain could be assembled in one single PCR step.

2.2.8 Thus, document D9 teaches a method of creating a polynucleotide library in which the variant motifs, represented by the internal primers L2, L3 and L5, are produced by chemical synthesis. The variant protein motifs are assembled with the scaffold sequence, represented by internal primers L1, L4 and L6 by PCR. Accordingly, steps (b), (c) and (d) of the method of claim 1 are disclosed in combination in document D9.

2.2.9 The method of claim 1 differs from the method of document D9 in that the variant sequences are obtained by amplification of nucleotide sequences from a parent polynucleotide encoding variant protein motifs, rather than by chemical synthesis.

2.2.10 The objective technical problem for the skilled person starting from the method of document D9 is the provision of an alternative method for creating a polynucleotide library. The solution to that problem is a method in which the variant sequences are obtained by amplification from a parent polynucleotide encoding variant protein motifs.

2.2.11 The question to be solved for the assessment of inventive step is whether, in order to provide variant sequences, the skilled person would have been prompted at the relevant filing date to replace in the method of document D9 the chemical synthesis by an amplification of pre-formed variant motifs taken from a parent polynucleotide.

2.2.12 Respondent I argues that the skilled person equipped with common general knowledge would have substituted amplification synthesis for the chemical synthesis. The Board is not convinced. Indeed, on the contrary, the skilled person scrutinising the statement on page 269 (right hand column) of document D9 which reads: "Instead of depending on in vivo preformed Ab specificities found in gene libraries, we have investigated an alternative route for the design and construction of V-region libraries" would have realised that the whole concept of the document was to construct entirely in vitro synthetic gene libraries for the variable light chain. Thus, document D9 teaches away from use of pre-formed sequences.

2.2.13 Respondent II argues that either document D12 (see point 2.1.3, supra) or document D25 (which provides a basic detailed description of the gene splicing by overlap extension) would have prompted the skilled person to replace the chemical synthesis in the method of document D9 by an amplification of pre-formed variant motifs taken from a parent polynucleotide. The Board is not convinced. As explained above (see point 2.2.12, supra) the skilled person interested in the alternative route for the design and construction of V-region gene libraries described in document D9 would have had no reason to pay attention to any document which as document D12 or document D25 described a polymerase chain reaction-based technology.

2.2.14 For these reasons the skilled person would have found no suggestion to substitute an amplification synthesis for the chemical synthesis of document D9.

2.2.15 Therefore, the method according to claim 1 involves an inventive step. The same conclusion applies de facto to the particular embodiments covered by dependent claims 2 to 8.

2.3 Sufficiency of disclosure (Article 83 EPC)

2.3.1 The method of claim 1 inherently comprises a step of isolating the amplified nucleotide sequences (see the reference in step b) to "the thus-isolated amplified nucleotide sequences").

2.3.2 Actually, the description, in both its general and experimental parts, indicates that those sequences may be isolated using members of a specific binding pair (MSBPs), such as biotin and avidin, (see page 6, lines 4 to 10; page 9, lines 6 to 10; page 10 (comments on Figure 5); page 11 (comments on Figure 8); page 13, lines 30 to 32; page 18, lines 25 to 28; and page 20, lines 2 to 6).

2.3.3 Whereas it can be concluded that the description describes in detail at least one way of carrying out the isolation of the amplified nucleotide sequences referred to in step b) of claim 1, the respondents argue that later document D29 (expert opinion) shows that the method of claim 1 cannot be put into effect without linking one of each pair of oligonucleotides as referred to in step a) of the claimed method to a MSBP, such as biotin.

2.3.4 Document D29 is a post-published document to which the inventors of the patent contributed. It illustrates the construction of a particular gene library encoding soluble domains of the variable region of an immunoglobulin heavy chain using a master framework together with in vivo formed PCR amplified complementary determining regions.

2.3.5 Whereas in the particular process described in document D29, use of biotin is made to obtain single stranded nucleotide sequences, it is not stated that such a use is essential and that those sequences could not be isolated using another MSBP or another technology. Thus, document D29 does not provide any serious doubts, substantiated by verifiable facts - see decision T 19/90 (OJ EPO 1990, 476) - and the respondents' argument fails.

2.3.6 Therefore, the method according to claim 1 is sufficiently disclosed. As the sufficiency of disclosure of the embodiments of the invention according to dependent claims 2 to 8 has not been questioned, it is concluded that auxiliary request 1 as a whole meets the requirement of Article 83 EPC.

Order

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the first instance with the order to maintain the patent on the basis of the auxiliary request 1 filed on 17 September 2007 and a description and drawings to be adapted thereto

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility